Free Trial

Genetron (GTH) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
50-Day Range
52-Week Range
412,600 shs
Average Volume
51,662 shs
Market Capitalization
$127.43 million
P/E Ratio
Dividend Yield
Price Target
GTH stock logo

About Genetron Stock (NASDAQ:GTH)

Genetron Holdings Limited, a precision oncology platform company, focuses on cancer management by utilizing technologies in molecular biology and data science in the People's Republic of China. It offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. The company also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. Genetron Holdings Limited was founded in 2013 and is headquartered in Beijing, the People's Republic of China.

GTH Stock News Headlines

270x more lucrative than NVIDIA???
Is the AI boom losing steam? According to the Wall Street Journal, the pace of innovation in AI is slowing down... Its usefulness is limited... And the cost of running AI remains "exorbitant."
Genetron (NASDAQ: GTH)
Genetron Holdings Ltd. ADR
270x more lucrative than NVIDIA???
Is the AI boom losing steam? According to the Wall Street Journal, the pace of innovation in AI is slowing down... Its usefulness is limited... And the cost of running AI remains "exorbitant."
Genetron Holdings' Enticing Arbitrage Return
Genetron Holdings Ltd ADR GTH
See More Headlines
Receive GTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genetron and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Fiscal Year End

Industry, Sector and Symbol

Diagnostics & Research
Current Symbol
Year Founded


Pretax Margin


Sales & Book Value

Annual Sales
$94.34 million
Book Value
$2.63 per share


Free Float
Market Cap
$127.43 million
Not Optionable
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. Sizhen Wang (Age 47)
    Co-Founder, CEO & Chairman
  • Dr. Wei-Wu He Ph.D. (Age 59)
    Co-Founder & Chairman Emeritus
  • Dr. Hai Yan M.D. (Age 56)
    Ph.D., Co-Founder, Chief Scientific Officer & Director
  • Mr. Ce Xu (Age 42)
    Chief Financial Officer
  • Ms. Victoria Lei
    Chief Operating Officer
  • Dr. Yuchen Jiao M.D. (Age 46)
    Ph.D., Chief Technology Officer
  • Mr. Yong Liang (Age 50)
    Chief Human Resources Officer
  • Dr. Yun-Fu Hu Ph.D. (Age 61)
    Chief Medical Officer
  • Ms. Lily Liu
    Chief Commercial Officer

GTH Stock Analysis - Frequently Asked Questions

How were Genetron's earnings last quarter?

Genetron Holdings Limited (NASDAQ:GTH) announced its quarterly earnings data on Sunday, May, 23rd. The company reported ($0.51) EPS for the quarter, missing the consensus estimate of ($0.21) by $0.30. The business had revenue of $14.05 million for the quarter.
Read the conference call transcript

When did Genetron's stock split?

Genetron's stock reverse split on Thursday, October 26th 2023. The 1-3 reverse split was announced on Thursday, October 26th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 26th 2023. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

When did Genetron IPO?

Genetron (GTH) raised $162 million in an initial public offering on Friday, June 19th 2020. The company issued 13,000,000 shares at a price of $11.50-$13.50 per share. Credit Suisse and CICC served as the underwriters for the IPO and BTIG and Canaccord Genuity were co-managers.

This page (NASDAQ:GTH) was last updated on 7/23/2024 by Staff

From Our Partners